Corporate News     23-Aug-22
Unichem Laboratories receives USFDA approval for Carbamazepine Tablets
Unichem Laboratories has received ANDA approval for its Carbamazepine Tablets USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TEGRETOL® (Carbamazepine) Tablet, 200 mg of Novartis Pharmaceuticals Corp.

Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia. The product will be commercialized from Unichem's Goa Plant.

Previous News
  Unichem Laboratories AGM scheduled
 ( Corporate News - 24-Aug-23   14:41 )
  Unichem Laboratories reports consolidated net loss of Rs 11.49 crore in the June 2021 quarter
 ( Results - Announcements 31-Jul-21   15:01 )
  Board of Unichem Laboratories appoints director
 ( Corporate News - 20-Mar-23   11:16 )
  Unichem Laboratories reports consolidated net loss of Rs 0.67 crore in the June 2023 quarter
 ( Results - Announcements 14-Jul-23   18:40 )
  Unichem Labs drops 22% in six days
 ( Hot Pursuit - 05-Dec-22   13:12 )
  Unichem Laboratories receives reaffirmation in ratings for LT bank facilities
 ( Corporate News - 26-Nov-21   12:53 )
  Unichem Laboratories reports consolidated net loss of Rs 14.60 crore in the December 2019 quarter
 ( Results - Announcements 03-Feb-20   16:48 )
  Unichem Laboratories reports standalone net loss of Rs 23.28 crore in the June 2022 quarter
 ( Results - Announcements 09-Aug-22   15:01 )
  Unichem Laboratories receives USFDA approval for Tadalafil Tablets
 ( Corporate News - 27-Mar-19   18:07 )
  Unichem Labs gains ater USFDA approval for celecoxib capsules
 ( Hot Pursuit - 13-Jan-21   13:10 )
  Unichem Laboratories reports consolidated net loss of Rs 23.37 crore in the June 2022 quarter
 ( Results - Announcements 09-Aug-22   15:33 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top